RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Regen BioPharma Inc
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026
- Market cap
- $92.33K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Regen BioPharma has not reported a dividend
No dividend per share appears in Regen BioPharma's annual filings since fiscal 2012.